đź“Š Evidence-Based Reference
radiation planning assistant rpa
University Of Texas, Md Anderson Cancer Center
Summary: The Radiation Planning Assistant (RPA) is a web-based tool designed to automate radiotherapy planning, primarily for clinics with limited resources. Key evidence highlights its potential to improve access to cancer care globally.
FDA Clearance Information
Pathway
510K
Number
K222728 ↗
Decision Date
May 17, 2023
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
The Radiation Planning Assistant RPA was cleared by the FDA via the 510(k) pathway on May 17, 2023. It is manufactured by the University Of Texas, Md Anderson Cancer Center and classified as a Class 2 device.
What It Is
The Radiation Planning Assistant is a web-based tool that automates radiotherapy contouring and planning. It is intended to support clinics with limited resources by providing automated treatment planning capabilities.
Clinical Applications
The RPA is commonly used in scenarios where there is a need to streamline radiotherapy planning, particularly in low-resource settings. It helps reduce planning time and improve access to radiotherapy services.
Evidence Summary
The available literature includes 10 studies, with types ranging from RCTs to retrospective analyses, published between 2023 and 2024. These studies focus on the feasibility and clinical acceptability of the RPA.
Reported Outcomes
Published studies report that the RPA can significantly reduce radiotherapy planning time and improve workflow efficiency in resource-constrained settings. It has been shown to enhance the ability of clinics to deliver timely cancer care.
Safety Profile
Reported complications include potential errors in automated contouring, which require clinician oversight. No significant adverse events have been reported in the studies reviewed.
Evidence Limitations
The evidence is limited by the small number of studies and the focus on low-resource settings. Further research is needed to assess long-term outcomes and the device's applicability in diverse clinical environments.
Frequently Asked Questions
What are the clinical indications for Radiation Planning Assistant RPA?
The RPA is indicated for use in automating radiotherapy planning, particularly in clinics with limited resources.
What outcomes have been reported in clinical studies?
Studies report improved planning efficiency and enhanced access to radiotherapy services in low-resource settings.
What complications have been reported?
Safety data indicate potential errors in automated contouring, necessitating clinician oversight.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.